Item Type | Name |
Concept
|
Arrhythmias, Cardiac
|
Concept
|
Sodium-Potassium-Exchanging ATPase
|
Concept
|
Arterioles
|
Concept
|
Captopril
|
Concept
|
Collagen
|
Concept
|
Carcinoma
|
Concept
|
Cell Count
|
Concept
|
Cattle
|
Concept
|
Blood Urea Nitrogen
|
Concept
|
Body Weight
|
Concept
|
Capillaries
|
Concept
|
Cisplatin
|
Concept
|
Creatinine
|
Concept
|
Actins
|
Concept
|
Arteries
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Clofibrate
|
Concept
|
Cyclic N-Oxides
|
Concept
|
Aminopeptidases
|
Concept
|
Cricetulus
|
Concept
|
Dextrans
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Diet
|
Concept
|
Drug Implants
|
Concept
|
Cyclic AMP
|
Concept
|
Antioxidants
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Albuminuria
|
Concept
|
Ascitic Fluid
|
Concept
|
Administration, Oral
|
Concept
|
Alprostadil
|
Concept
|
Acetylcholine
|
Concept
|
Aorta
|
Concept
|
Arachidonic Acids
|
Concept
|
Estradiol
|
Concept
|
Eye Diseases
|
Concept
|
Fatty Acids, Monounsaturated
|
Concept
|
Cardiotonic Agents
|
Concept
|
Benzoates
|
Concept
|
Fatty Acids
|
Concept
|
Chronic Disease
|
Concept
|
Cell Adhesion
|
Concept
|
Cholesterol
|
Concept
|
Cardiovascular Diseases
|
Concept
|
Hydrogen Peroxide
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Autophagy
|
Concept
|
Calcium Channel Blockers
|
Concept
|
Cells, Cultured
|
Concept
|
Brain Ischemia
|
Concept
|
Obesity
|
Concept
|
Aryl Hydrocarbon Hydroxylases
|
Concept
|
Chenodeoxycholic Acid
|
Concept
|
Golgi Apparatus
|
Concept
|
Coronary Vessels
|
Concept
|
Delayed-Action Preparations
|
Concept
|
Base Sequence
|
Concept
|
Blood Vessels
|
Concept
|
Cell Separation
|
Concept
|
Fatty Acids, Unsaturated
|
Concept
|
Diabetes Mellitus, Experimental
|
Concept
|
Endothelium, Vascular
|
Concept
|
Microsomes
|
Concept
|
Blood Pressure
|
Concept
|
Cerebral Infarction
|
Concept
|
Follicle Stimulating Hormone
|
Concept
|
HeLa Cells
|
Concept
|
Diabetes Mellitus, Type 2
|
Concept
|
Drug Synergism
|
Concept
|
Potassium Chloride
|
Concept
|
Hypnotics and Sedatives
|
Concept
|
Hypertension, Renovascular
|
Concept
|
Pulmonary Artery
|
Concept
|
Severity of Illness Index
|
Concept
|
Metabolic Diseases
|
Concept
|
Mesenteric Arteries
|
Concept
|
Tetraethylammonium Compounds
|
Concept
|
Myocardial Infarction
|
Concept
|
Necrosis
|
Concept
|
8,11,14-Eicosatrienoic Acid
|
Concept
|
Orchiectomy
|
Concept
|
Renin
|
Concept
|
Down-Regulation
|
Concept
|
Myocardial Reperfusion Injury
|
Concept
|
Oleic Acids
|
Concept
|
Microvilli
|
Concept
|
Interleukin-6
|
Concept
|
Calcium
|
Concept
|
Cell Survival
|
Concept
|
Receptor, Endothelin A
|
Concept
|
Oxamic Acid
|
Concept
|
Potassium
|
Concept
|
Rats, Inbred F344
|
Concept
|
Chemokine CCL2
|
Concept
|
Linoleic Acid
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
3T3 Cells
|
Concept
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
|
Concept
|
Receptors, CCR2
|
Concept
|
Xenograft Model Antitumor Assays
|
Concept
|
Calcium Signaling
|
Concept
|
Eicosanoids
|
Concept
|
Disease Progression
|
Concept
|
Matrix Metalloproteinase 2
|
Concept
|
Cell Proliferation
|
Concept
|
Epoxide Hydrolases
|
Concept
|
Glomerular Basement Membrane
|
Concept
|
Fas Ligand Protein
|
Concept
|
Adenosine A2 Receptor Agonists
|
Concept
|
Receptors, CCR1
|
Concept
|
Endothelin-1
|
Concept
|
3' Untranslated Regions
|
Concept
|
Leptin
|
Concept
|
Cyclic GMP
|
Concept
|
Heart Failure
|
Concept
|
Flow Cytometry
|
Concept
|
Epithelial-Mesenchymal Transition
|
Concept
|
Fenofibrate
|
Concept
|
Risk Factors
|
Concept
|
Enzyme Induction
|
Concept
|
Hypertension, Renal
|
Concept
|
Lauric Acids
|
Concept
|
Nitrites
|
Concept
|
NF-kappa B
|
Concept
|
Patch-Clamp Techniques
|
Concept
|
PPAR gamma
|
Concept
|
Sodium Chloride
|
Concept
|
Blotting, Western
|
Concept
|
Cell Death
|
Concept
|
Prostaglandins E, Synthetic
|
Concept
|
Hypertrophy, Left Ventricular
|
Concept
|
Receptor, Angiotensin, Type 1
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Intracellular Membranes
|
Concept
|
Receptors, Adrenergic, alpha-2
|
Concept
|
Osteopontin
|
Concept
|
DNA Primers
|
Concept
|
Natriuresis
|
Concept
|
Gallic Acid
|
Concept
|
Metabolic Networks and Pathways
|
Concept
|
Obesity, Abdominal
|
Concept
|
HEK293 Cells
|
Concept
|
Endothelial Cells
|
Concept
|
Cell Line, Tumor
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
Concept
|
Clinical Trials as Topic
|
Concept
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
|
Concept
|
Enzyme Activation
|
Concept
|
Epoxy Compounds
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Arterio-Arterial Fistula
|
Concept
|
Bradykinin
|
Concept
|
Fibroblasts
|
Concept
|
Fructose
|
Concept
|
Chemotaxis, Leukocyte
|
Concept
|
Cobalt
|
Concept
|
Drug Discovery
|
Concept
|
Cross-Linking Reagents
|
Concept
|
Dogs
|
Concept
|
Fatty Liver
|
Concept
|
Immunohistochemistry
|
Concept
|
Heart Diseases
|
Concept
|
Insulin
|
Concept
|
Hydrochlorothiazide
|
Concept
|
Receptor, Endothelin B
|
Concept
|
Diabetes Mellitus, Type 1
|
Concept
|
Epithelium
|
Concept
|
Receptor, Bradykinin B2
|
Concept
|
Purinergic P2 Receptor Agonists
|
Concept
|
Glucose Tolerance Test
|
Concept
|
Membrane Potentials
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
Concept
|
Fluoresceins
|
Concept
|
Cardiomegaly
|
Concept
|
Hypertension, Malignant
|
Concept
|
Matrix Metalloproteinase 9
|
Concept
|
Hypertension
|
Concept
|
Kidney Diseases
|
Concept
|
Hydroxyeicosatetraenoic Acids
|
Concept
|
Diabetic Nephropathies
|
Concept
|
Human Umbilical Vein Endothelial Cells
|
Concept
|
Metalloendopeptidases
|
Concept
|
Muscle, Smooth, Vascular
|
Concept
|
Peptidyl-Dipeptidase A
|
Concept
|
Norepinephrine
|
Concept
|
Syndrome
|
Concept
|
Peritoneal Neoplasms
|
Concept
|
Epithelial Sodium Channels
|
Concept
|
Sodium
|
Concept
|
Weight Gain
|
Concept
|
Radiation Injuries, Experimental
|
Concept
|
Endosomes
|
Concept
|
Dinoprostone
|
Concept
|
Tachycardia, Ventricular
|
Concept
|
Superoxides
|
Concept
|
Receptors, Bradykinin
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Chemokines
|
Concept
|
Fatty Acids, Omega-3
|
Concept
|
Ion Channel Gating
|
Concept
|
Steroid 16-alpha-Hydroxylase
|
Concept
|
Survival Rate
|
Concept
|
Phosphoprotein Phosphatases
|
Concept
|
In Situ Hybridization
|
Concept
|
Substance P
|
Concept
|
Arachidonic Acid
|
Concept
|
Renal Artery
|
Concept
|
Protein Phosphatase 2
|
Concept
|
Apoptosis
|
Concept
|
Paracrine Communication
|
Concept
|
Thromboxane B2
|
Concept
|
CHO Cells
|
Concept
|
Epigenesis, Genetic
|
Concept
|
Isoprostanes
|
Concept
|
Cyclosporine
|
Concept
|
Diet, High-Fat
|
Concept
|
Transforming Growth Factor beta1
|
Concept
|
PPAR alpha
|
Concept
|
Cerebral Arteries
|
Concept
|
Diabetes Mellitus
|
Concept
|
Dietary Fats
|
Concept
|
Disease Models, Animal
|
Concept
|
Drug Administration Schedule
|
Concept
|
Intercellular Adhesion Molecule-1
|
Concept
|
HL-60 Cells
|
Concept
|
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
|
Concept
|
Receptors, Prostaglandin E
|
Concept
|
Receptors, Prostaglandin E, EP2 Subtype
|
Concept
|
Cytochrome P-450 CYP1A1
|
Concept
|
Receptor, Adenosine A2B
|
Concept
|
Vascular Endothelial Growth Factor A
|
Concept
|
Angiotensin II Type 2 Receptor Blockers
|
Concept
|
Inflammasomes
|
Concept
|
Receptor, Cannabinoid, CB2
|
Concept
|
Nitric Oxide Synthase Type III
|
Concept
|
Microvessels
|
Concept
|
Transcription Factor RelA
|
Concept
|
Chemistry Techniques, Synthetic
|
Concept
|
Receptors, Prostaglandin E, EP1 Subtype
|
Concept
|
ortho-Aminobenzoates
|
Concept
|
Endoplasmic Reticulum Stress
|
Concept
|
Phosphates
|
Concept
|
Virus Diseases
|
Concept
|
Coculture Techniques
|
Concept
|
U937 Cells
|
Concept
|
Calcium Channels, L-Type
|
Concept
|
Dinoprost
|
Concept
|
Signal Transduction
|
Concept
|
Cytokines
|
Concept
|
Endothelins
|
Concept
|
Okadaic Acid
|
Concept
|
Peroxisome Proliferator-Activated Receptors
|
Academic Article
|
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
|
Academic Article
|
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.
|
Academic Article
|
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
|
Academic Article
|
Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions.
|
Academic Article
|
Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats.
|
Academic Article
|
Afferent Arteriolar Responses to ?,?-methylene ATP and 20-HETE are not Blocked by ENaC Inhibition.
|
Academic Article
|
Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells.
|
Academic Article
|
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
|
Academic Article
|
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.
|
Academic Article
|
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.
|
Academic Article
|
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
|
Academic Article
|
Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats.
|
Academic Article
|
Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation.
|
Academic Article
|
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
|
Academic Article
|
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin.
|
Academic Article
|
Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
|
Academic Article
|
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.
|
Academic Article
|
Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats.
|
Academic Article
|
Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
|
Academic Article
|
Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.
|
Academic Article
|
Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats.
|
Academic Article
|
Cytochrome P450 epoxygenases provide a novel mechanism for penile erection.
|
Academic Article
|
Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension.
|
Academic Article
|
Reply to "Letter to the editor: 'Concern regarding quantification of urinary nephrin by commercially available ELISA'".
|
Academic Article
|
Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation.
|
Academic Article
|
SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection.
|
Academic Article
|
Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
|
Academic Article
|
Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
|
Academic Article
|
Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats.
|
Academic Article
|
Obesity, insulin resistance, and renal function.
|
Academic Article
|
Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.
|
Academic Article
|
Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice.
|
Academic Article
|
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.
|
Academic Article
|
Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension.
|
Academic Article
|
Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype Changes.
|
Academic Article
|
Eicosanoids and renal vascular function in diseases.
|
Academic Article
|
The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats.
|
Academic Article
|
Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
|
Academic Article
|
Renal AT1 receptor protein expression during the early stage of diabetes mellitus.
|
Academic Article
|
Normalization of the ovarian cancer microenvironment by SPARC.
|
Academic Article
|
Epoxides and soluble epoxide hydrolase in cardiovascular physiology.
|
Academic Article
|
Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats.
|
Academic Article
|
11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.
|
Academic Article
|
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
|
Academic Article
|
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis.
|
Academic Article
|
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
|
Academic Article
|
Epoxylipids and soluble epoxide hydrolase in heart diseases.
|
Academic Article
|
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.
|
Academic Article
|
Dual sEH/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity.
|
Academic Article
|
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice.
|
Academic Article
|
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
|
Academic Article
|
Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats.
|
Academic Article
|
Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
|
Academic Article
|
Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.
|
Academic Article
|
Renal blood flow autoregulation: what are the contributions for nitric oxide or superoxide to modulate the myogenic response?
|
Academic Article
|
Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats.
|
Academic Article
|
20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
|
Academic Article
|
Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats.
|
Academic Article
|
Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1a via downregulation of prolyl hydroxylase 3.
|
Academic Article
|
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice.
|
Academic Article
|
Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice.
|
Academic Article
|
Radiation-induced afferent arteriolar endothelial-dependent dysfunction involves decreased epoxygenase metabolites.
|
Academic Article
|
Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.
|
Academic Article
|
Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids.
|
Academic Article
|
Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
|
Academic Article
|
Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis.
|
Academic Article
|
Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.
|
Academic Article
|
Multi-Target Drugs for Kidney Diseases.
|
Academic Article
|
Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.
|
Academic Article
|
Epoxyeicosatrienoic acids, hypertension, and kidney injury.
|
Academic Article
|
Editorial: Interactions Between Podocytes, Mesangial Cells, and Glomerular Endothelial Cells in Glomerular Diseases.
|
Academic Article
|
p66Shc regulates renal vascular tone in hypertension-induced nephropathy.
|
Academic Article
|
Increased blood pressure in mice lacking cytochrome P450 2J5.
|
Academic Article
|
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
|
Academic Article
|
A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.
|
Academic Article
|
Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart.
|
Academic Article
|
Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.
|
Academic Article
|
Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.
|
Academic Article
|
Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.
|
Academic Article
|
Adaptations of the renal microcirculation to hypertension.
|
Academic Article
|
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor ? agonist improve vascular function and decrease renal injury in hypertensive obese rats.
|
Academic Article
|
Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.
|
Academic Article
|
Eicosanoids and renal damage in cardiometabolic syndrome.
|
Academic Article
|
Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.
|
Academic Article
|
Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
|
Academic Article
|
Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats.
|
Academic Article
|
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
|
Academic Article
|
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
|
Academic Article
|
Anti-inflammatory effects of ?-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
|
Academic Article
|
Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice.
|
Academic Article
|
Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.
|
Academic Article
|
Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors.
|
Academic Article
|
Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.
|
Academic Article
|
12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels.
|
Academic Article
|
Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.
|
Academic Article
|
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.
|
Academic Article
|
SPARC ameliorates ovarian cancer-associated inflammation.
|
Academic Article
|
Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.
|
Academic Article
|
Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats.
|
Academic Article
|
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
|
Academic Article
|
The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin.
|
Academic Article
|
Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans.
|
Academic Article
|
The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.
|
Academic Article
|
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet.
|
Academic Article
|
ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement.
|
Academic Article
|
Combined treatment with epoxyeicosatrienoic acid analog and 20-hydroxyeicosatetraenoic acid antagonist provides substantial hypotensive effect in spontaneously hypertensive rats.
|
Academic Article
|
Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases.
|
Academic Article
|
Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
|
Academic Article
|
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
|
Academic Article
|
Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.
|
Academic Article
|
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
|
Academic Article
|
The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.
|
Academic Article
|
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.
|
Academic Article
|
Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.
|
Academic Article
|
Fructose stimulates Na/H exchange activity and sensitizes the proximal tubule to angiotensin II.
|
Academic Article
|
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation.
|
Academic Article
|
Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.
|
Academic Article
|
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors.
|
Academic Article
|
Dual soluble epoxide hydrolase inhibitor/PPAR-? agonist attenuates renal fibrosis.
|
Academic Article
|
Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats.
|
Academic Article
|
Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition.
|
Academic Article
|
Rofecoxib decreases renal injury in obese Zucker rats.
|
Academic Article
|
P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid.
|
Academic Article
|
Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor.
|
Academic Article
|
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension.
|
Academic Article
|
20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension.
|
Academic Article
|
Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.
|
Academic Article
|
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.
|
Academic Article
|
Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity.
|
Academic Article
|
Orally Active Epoxyeicosatrienoic Acid Analogs.
|
Academic Article
|
Adenosine2A receptors and epoxyeicosatrienoic acids: a recipe for salt and blood pressure regulation.
|
Academic Article
|
Diabetes risk associated with plasma epoxylipid levels.
|
Academic Article
|
Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat.
|
Academic Article
|
Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
|
Academic Article
|
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.
|
Academic Article
|
Epigenetic soluble epoxide hydrolase regulation causes endothelial dysfunction.
|
Academic Article
|
CYP450, COX-2 and Obesity Related Renal Damage.
|
Academic Article
|
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
|
Academic Article
|
Eicosanoid blood vessel regulation in physiological and pathological states.
|
Academic Article
|
Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade.
|
Academic Article
|
14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.
|
Academic Article
|
Cytochrome P450 eicosanoids and cerebral vascular function.
|
Academic Article
|
Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors.
|
Academic Article
|
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.
|
Academic Article
|
Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
|
Academic Article
|
Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.
|
Academic Article
|
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
|
Academic Article
|
A SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE.
|
Academic Article
|
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
|
Academic Article
|
Targeting epoxides for organ damage in hypertension.
|
Academic Article
|
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.
|
Academic Article
|
Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
|
Academic Article
|
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
|
Academic Article
|
Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats.
|
Academic Article
|
Loss of Chloride Channel 6 (CLC-6) Affects Vascular Smooth Muscle Contractility and Arterial Stiffness via Alterations to Golgi Calcium Stores.
|
Academic Article
|
Editorial: Renal Function in Acute and Chronic Kidney Diseases.
|
Academic Article
|
Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats.
|
Academic Article
|
20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis?
|
Academic Article
|
Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.
|
Academic Article
|
PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats.
|
Academic Article
|
Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity.
|
Academic Article
|
Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.
|
Academic Article
|
Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats.
|
Academic Article
|
Immune and inflammatory role in renal disease.
|
Academic Article
|
THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODEL.
|
Academic Article
|
L-type calcium channels in the renal microcirculatory response to endothelin.
|
Academic Article
|
Multi-Target Approaches in Metabolic Syndrome.
|
Academic Article
|
Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.
|
Academic Article
|
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.
|
Academic Article
|
Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.
|
Academic Article
|
Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
|
Academic Article
|
A novel dual PPAR-? agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.
|
Academic Article
|
Frontiers in metabolic physiology grand challenges.
|
Academic Article
|
Editorial: The future of physiology: 2020 and beyond, Volume III.
|
Academic Article
|
Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD.
|
Academic Article
|
Salt-sensitive hypertension after reversal of unilateral ureteral obstruction.
|
Academic Article
|
Bioactive lipids in hypertension.
|
Academic Article
|
Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension.
|
Academic Article
|
Editorial: Nuclear receptors in hemodynamics and blood pressure control.
|
Grant
|
Eicosanoid-based Therapy for Diabetes
|
Grant
|
Epoxyeicosanoids and Renal Vascular Function in Obesity &Hypertension
|
Grant
|
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITY
|
Grant
|
Novel epoxide hydrolase inhibitor for stroke prevention
|
Academic Article
|
Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis.
|
Academic Article
|
Kidney Injury by Unilateral Ureteral Obstruction in Mice Lacks Sex Differences.
|